Update on antibiotics for infection control in cystic fibrosis

Stephen Kirkby1, Kimberly Novak, Karen McCoy

  • 1Section of Pulmonary Medicine, Nationwide Children's Hospital, Ohio State University Medical Center, Columbus, OH 43205, USA. stephen.kirkby@nationwidechildrens.org

Insights

Cystic fibrosis lung infections, like Pseudomonas aeruginosa, are hard to eradicate. This review covers current anti-infective strategies for acute and chronic infections in cystic fibrosis patients.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Cystic Fibrosis Research

Background:

  • Cystic fibrosis lung disease involves chronic infections, inflammation, and airway obstruction.
  • Pseudomonas aeruginosa is a common pathogen in cystic fibrosis, with improved survival due to treatments.
  • Antibiotic resistance, toxicity, and treatment burden limit current anti-infective options.

Purpose of the Study:

  • To review current anti-infective therapy approaches for cystic fibrosis.
  • To discuss challenges in eradicating airway infections in cystic fibrosis.
  • To summarize strategies for acute and chronic infections.

Main Methods:

  • Literature review of anti-infective therapies in cystic fibrosis.
  • Analysis of treatment options for Pseudomonas aeruginosa and other common pathogens.
  • Summary of current clinical practices and challenges.

Main Results:

  • Anti-infective therapy can reduce bacterial load and improve clinical status.
  • Complete eradication of airway infections is rarely achieved, except in early stages.
  • Multidrug resistance and treatment limitations impact therapeutic effectiveness.

Conclusions:

  • Current anti-infective strategies offer improvements but face significant challenges.
  • Further research is needed to overcome resistance and improve eradication rates.
  • Optimizing acute and chronic anti-infective therapy remains critical for cystic fibrosis patients.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...